108 related articles for article (PubMed ID: 19281284)
1. Targeted renal therapy: a potential weapon in the battle against CIN.
Boyle JR
J Endovasc Ther; 2009 Feb; 16(1):13-4. PubMed ID: 19281284
[No Abstract] [Full Text] [Related]
2. Safety and performance of targeted renal therapy: the Be-RITe! Registry.
Weisz G; Filby SJ; Cohen MG; Allie DE; Weinstock BS; Kyriazis D; Walker CM; Moses JW; Danna P; Fearon WF; Sachdev N; Wiechmann BN; Vora K; Findeiss L; Price MJ; Mehran R; Leon MB; Teirstein PS
J Endovasc Ther; 2009 Feb; 16(1):1-12. PubMed ID: 19281283
[TBL] [Abstract][Full Text] [Related]
3. Prevention of contrast-induced nephropathy with sodium bicarbonate.
Siegel RE
JAMA; 2004 Sep; 292(12):1428; author reply 1428-9. PubMed ID: 15383508
[No Abstract] [Full Text] [Related]
4. Sodium bicarbonate vs sodium chloride in preventing contrast medium-induced nephropathy.
Shy BD; Gupta A; Hoffman RS
JAMA; 2009 Jan; 301(4):377-8; author reply 379-380. PubMed ID: 19176435
[No Abstract] [Full Text] [Related]
5. Direct infusion of fenoldopam into the renal arteries to protect against contrast-induced nephropathy in patients at increased risk.
Talati S; Kirtane AJ; Hassanin A; Mehran R; Leon MB; Moses JW; Weisz G
Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):506-9. PubMed ID: 22469256
[TBL] [Abstract][Full Text] [Related]
6. Selective renal arterial infusion of fenoldopam for the prevention of contrast-induced nephropathy.
Ng MK; Tremmel J; Fitzgerald PJ; Fearon WF
J Interv Cardiol; 2006 Feb; 19(1):75-9. PubMed ID: 16483344
[TBL] [Abstract][Full Text] [Related]
7. Intravenous N-acetylcysteine in the prevention of contrast media-induced nephropathy.
Anderson SM; Park ZH; Patel RV
Ann Pharmacother; 2011 Jan; 45(1):101-7. PubMed ID: 21205947
[TBL] [Abstract][Full Text] [Related]
8. Sodium bicarbonate vs sodium chloride in preventing contrast medium-induced nephropathy.
Kanbay M; Kasapoglu B; Akcay A
JAMA; 2009 Jan; 301(4):378; author reply 379-380. PubMed ID: 19176438
[No Abstract] [Full Text] [Related]
9. Letter by Wetzels regarding article, "Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies".
Wetzels JF
Circulation; 2007 Aug; 116(8):e310; author reply e311. PubMed ID: 17709647
[No Abstract] [Full Text] [Related]
10. Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy.
Adolph E; Holdt-Lehmann B; Chatterjee T; Paschka S; Prott A; Schneider H; Koerber T; Ince H; Steiner M; Schuff-Werner P; Nienaber CA
Coron Artery Dis; 2008 Sep; 19(6):413-9. PubMed ID: 18955835
[TBL] [Abstract][Full Text] [Related]
11. Sodium bicarbonate vs sodium chloride in preventing contrast medium-induced nephropathy.
Burgess W; Merten GJ; Rittase RA
JAMA; 2009 Jan; 301(4):377; author reply 379-380. PubMed ID: 19176436
[No Abstract] [Full Text] [Related]
12. Prevention of contrast-induced nephropathy with sodium bicarbonate.
Shavit L; Lifschitz M; Plaksin J; Slotki IN
JAMA; 2004 Sep; 292(12):1428; author reply 1428-9. PubMed ID: 15383507
[No Abstract] [Full Text] [Related]
13. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Briguori C; Airoldi F; D'Andrea D; Bonizzoni E; Morici N; Focaccio A; Michev I; Montorfano M; Carlino M; Cosgrave J; Ricciardelli B; Colombo A
Circulation; 2007 Mar; 115(10):1211-7. PubMed ID: 17309916
[TBL] [Abstract][Full Text] [Related]
14. Sodium bicarbonate vs sodium chloride in preventing contrast medium-induced nephropathy.
Bouzas-Mosquera A; Vázquez-Rodríguez JM; Peteiro J
JAMA; 2009 Jan; 301(4):378-9; author reply 379-380. PubMed ID: 19176437
[No Abstract] [Full Text] [Related]
15. Contrast-induced nephropathy: protective role of fenoldopam.
Caixeta A; Dogan O; Weisz G
Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):497-505. PubMed ID: 22642656
[TBL] [Abstract][Full Text] [Related]
16. Sodium bicarbonate for the prevention of contrast-induced nephropathy: the efficacy of high concentration solution.
Tamai N; Ito S; Nakasuka K; Morimoto K; Miyata K; Inomata M; Yoshida T; Suzuki S; Murakami Y; Sato K
J Invasive Cardiol; 2012 Sep; 24(9):439-42. PubMed ID: 22954563
[TBL] [Abstract][Full Text] [Related]
17. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based management of patients undergoing PCI: contrast-induced acute kidney injury.
Caixeta A; Mehran R
Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S15-20. PubMed ID: 20333702
[TBL] [Abstract][Full Text] [Related]
19. First experience with intra-renal fenoldopam in a patient with heart failure.
Cohen MG
J Invasive Cardiol; 2005 May; 17(5):274-6. PubMed ID: 15879609
[No Abstract] [Full Text] [Related]
20. Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial).
Lee SW; Kim WJ; Kim YH; Park SW; Park DW; Yun SC; Lee JY; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Suh J; Cho YH; Lee NH; Cheong SS; Yoo SY; Lee BK; Lee SG; Hyon MS; Shin WY; Lee SW; Jang JS; Park SJ
Am J Cardiol; 2011 May; 107(10):1447-52. PubMed ID: 21420063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
